Trending

Conatus

Conatus axes staff after latest failure of Novartis-partnered NASH drug

Conatus axes staff after latest failure of Novartis-partnered NASH drug

Conatus has said it will have to cut around 40% of its workforce and jettison some pipeline projects

X

Conatus axes staff after latest failure of Novartis-partnered NASH drug

https://pharmaphorum.com/news/conatus-axes-staff-after-latest-nash-trial-failure/

Novartis takes option on NASH drug from Conatus

Novartis takes option on NASH drug from Conatus

Swiss pharma takes option on FXR agonist emricasan.

X

Novartis takes option on NASH drug from Conatus

https://pharmaphorum.com/news/novartis-takes-option-nash/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com